Updated Jul 16, 2026
NEUPERT PETER M has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $407K.
Peter M. Neupert is a corporate executive known for his role as Chief Executive Officer and Director at Fortrea Holdings Inc., a company specializing in clinical trial management. He has a background in the biopharmaceutical industry and has held various leadership positions throughout his career.
| Role | Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-18 | FTRE | Fortrea Holdings Inc. | M — Option exercise | 148.5K | $0.00 | |
| 2026-03-07 | ADPT | Adaptive Biotechnologies Corp | A — Grant or award | 15.6K | $0.00 | |
| 2026-02-13 | LH | LABCORP HOLDINGS INC. | M — Option exercise | 897 | — | |
| 2025-08-08 | FTRE | Fortrea Holdings Inc. | P — Open-market purchase | 32.5K | $6.26 | $203K |
| 2025-08-08 | FTRE | Fortrea Holdings Inc. | P — Open-market purchase | 30.0K | $6.79 | $204K |
| 2025-05-14 | FTRE | Fortrea Holdings Inc. | M — Option exercise | 7.3K | $0.00 |
Peter M. Neupert is a corporate executive known for his role as Chief Executive Officer and Director at Fortrea Holdings Inc., a company specializing in clinical trial management. He has a background in the biopharmaceutical industry and has held various leadership positions throughout his career.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($407K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live NEUPERT PETER M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.